Viewing nowKayril Tablet 2 mg (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
KS Pharm Co., Ltd.

MFDS item code 201906365 · Approved 2019.09.09 · Insurance code 059000210
Improvement of blood glucose control in type 2 diabetes mellitus
This medication is used to help control blood sugar levels in patients with type 2 diabetes. It can be taken in conjunction with meal planning and exercise to effectively manage blood sugar. It can be taken alone, but in some cases, it may be combined with other hypoglycemic agents or insulin. For example, it can be administered alongside insulin when blood sugar control is inadequate with oral hypoglycemics or combined with metformin when monotherapy with sulfonylureas or metformin is insufficient. This medication plays an important role in systematically improving patients' blood sugar levels.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Administer this medicine orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1-2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, initiate treatment at 1 mg once daily and adjust the dose at intervals of 1-2 weeks. The potency and duration of action of the previous medicine should be considered. 4) Dose monitoring While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Despite successful initial management, hypoglycemia may recur with sulfonylurea medicines. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer this medicine at 8 mg once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If a patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes or those in diabetic ketoacidosis, or comatose patients. Additionally, patients with a history of allergic reactions to this medication or sulfonylureas or sulfonamide drugs should avoid administration. There is no experience with this medication in patients with severely impaired liver or kidney function, and transitioning to insulin therapy is recommended in such cases. Women who are pregnant or may become pregnant, as well as breastfeeding mothers, should not take this medication. Caution is also advised in patients with severe infections, pre- or post-surgical patients, or those who have experienced significant trauma, as insulin therapy may be necessary. Patients with gastrointestinal disorders should be cautious as food absorption may be impaired, increasing the risk of hypoglycemia. This medication contains lactose, and patients with lactose intolerance or certain genetic metabolic disorders should not take it. During the first week of starting this medication, there is a higher risk of hypoglycemia, so blood sugar levels should be closely monitored. This is especially pertinent for elderly patients, those who are malnourished or have irregular eating habits, and frequent alcohol consumers who have a greater risk of hypoglycemia. Patients with decreased kidney or liver function may also respond more sensitively to this medication, so dose adjustment may be necessary. Patients with other endocrine disorders or those taking multiple medications should carefully monitor their blood sugar levels. If symptoms of hypoglycemia occur, immediately inform a doctor or pharmacist and take appropriate action as prescribed. Symptoms of hypoglycemia may arise while taking this medication, including headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, decreased consciousness, etc. Hypoglycemia can usually be rapidly corrected by consuming sugar, so it is important to always carry glucose. Additionally, some patients may experience blurred vision, gastrointestinal disorders, liver dysfunction, blood abnormalities, or allergic reactions. If severe allergic reactions or blood abnormalities occur, stop taking the medication immediately and consult healthcare professionals. Regular medication adherence is crucial, and optimal blood sugar control can be achieved by combining dietary and exercise regimens. Patients and families should be adequately informed about the symptoms and risks of hypoglycemia so that they can handle hypoglycemic events appropriately. During treatment, regular monitoring of blood sugar, liver, and kidney function is necessary, and dose or administration method adjustments should be made according to changes in condition. Care should also be taken when driving or operating machinery, considering the possibility of decreased attention due to hypoglycemia. This medication may interact with other medications, so it is important to inform healthcare professionals of all medications being taken. In particular, blood sugar changes may occur when taken with certain antibiotics, analgesics, steroids, or beta-blockers. Alcohol consumption should be avoided as it can destabilize the blood sugar control effect of this medication. Pregnant or breastfeeding women are advised to consider insulin therapy instead, as it may affect the fetus or newborn. Safety and efficacy for children under 18 have not been established, so it is advisable not to use this medication in that population. Elderly patients may have reduced kidney function, so caution in dose adjustment is necessary. Severe hypoglycemia may occur in the event of overdose, and immediate medical attention should be sought for appropriate treatment. This medication should be kept out of reach of children and stored in its original container to maintain quality.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbance, anxiety, aggression, decreased concentration, decreased agility or motivation, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, transient mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and damp skin, tachycardia, hypertension, palpitations, angina, deep venous thrombosis, blurred vision, feeling of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, agranulocytosis, pancytopenia, itching, hives, rash, difficulty breathing, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photoreaction of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, indigestion, facial swelling, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly closed container. It is also recommended to store it at room temperature between 1 and 30 degrees Celsius.
Green oblong tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
KS Pharm Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.